MedTrace Logo

This Is A Study Of Bioavailability And Food Effect For Fesoterodine.

NCT01286454 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-01-26

Study results available
· View outcomes & findings →

Summary

This Is A Study Of Bioavailability And Food Effect For Fesoterodine.

Conditions

  • Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency

Interventions

DRUG

fesoterodine

single dose of beads in capsule

DRUG

fesoterodine

single dose of beads in capsule

DRUG

fesoterodine

single dose of beads in capsule

DRUG

fesoterodine

single dose of beads in capsule

DRUG

fesoterodine

single dose of tablet

DRUG

fesoterodine

single dose of beads in capsule

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01286454 on ClinicalTrials.gov